middle.news
ImpediMed Boosts Revenue 25% but Faces $12.3M Loss; Secures $5M Funding
9:08am on Thursday 26th of February, 2026 AEDT
•
Healthcare
Read Story
ImpediMed Boosts Revenue 25% but Faces $12.3M Loss; Secures $5M Funding
9:08am on Thursday 26th of February, 2026 AEDT
Key Points
Revenue increased 25% to $7.5 million, led by SOZO usage fees
Net loss widened slightly to $12.3 million from $11.1 million
Operating expenses and finance costs contributed to loss
Secured additional US$5 million funding tranche from SWK Funding LLC
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMPEDIMED (ASX:IPD)
OPEN ARTICLE